Tag Archive for: tumour

Illustrative look at the tight junctions of cell-cell interaction (provided by SYnAbs S.A.)
© SYnAbs S.A.

Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting Claudin-1 (CLDN1). The molecule is significantly involved in the tight junction between cells. Now the company closed a three digit million Seriec C round.